US EditionTop science stories of 2025
The first personalized CRISPR gene therapy was administered to a baby in 2025, and FDA approved initial pig organ transplant trials, marking milestones in gene editing and xenotransplantation.
- This year, a baby boy became the first patient to receive a personalized CRISPR therapy, while the Center for Pediatric CRISPR Cures in California launched, funded by the Chan Zuckerberg Initiative and led by UC Berkeley and UC San Francisco.
- A surge in gene‑therapy results helped pave the way as Amsterdam-based uniQure infused 29 Huntington's disease patients with microRNAs, slowing progression by 75% at higher doses.
- Regulators and surgeons advanced pig‑organ transplants as the Food and Drug Administration green‑lit multiperson pig kidney trials; experimental pig lung and kidney transplants included one lasting nearly nine months, while an enzyme for blood‑type conversion showed promise.
- Surgeons expect transplant volume to rise from current handfuls, with Joseph Ladowski forecasting about 'half a dozen' more animal‑organ transplants this year and a steep increase thereafter.
- Astronomers also scored a major win with Rubin coming online, featuring a 3.2 billion‑pixel camera and a project goal to catalog 5 million asteroids this year.
13 Articles
13 Articles
Top science stories of 2025
Kateryna Kon // Shutterstock 2025 was a year of turmoil for many scientists — particularly in the United States, where job cuts and budget slashing have left many reeling. But it was also a year of promising advances in fields from gene therapy to quantum computing. In the U.S., executive orders by President Donald Trump led to the loss of thousands of jobs in government agencies, including NASA, which oversees space exploration, and NOAA, whi…
RECIT - Never have the investments been so high for this promising technology, and some large groups are starting to equip themselves. But European start-ups in the sector will need massive financial support to keep themselves from being distanced.
OceanFirst to Buy Flushing Bank in $579M All-Stock Deal
OceanFirst Financial Corp. has struck a deal to buy Flushing Financial Corp., setting the stage for another major chapter in the fast-moving consolidation of U.S. community banking. The companies announced a definitive merger agreement Monday under which Flushing Bank will be folded into OceanFirst Bank in an all-stock transaction valued at about $579 million. The price reflects OceanFirst’s closing share price of $19.76 on Dec. 26, the banks sa…
OceanFirst, Flushing Bank agree to $579 million merger
OceanFirst Bank and Flushing Bank announced Dec. 29 they agreed to merge in an all-stock transaction valued at $579 million, its biggest ever, that would create a regional banking powerhouse with $23 billion in assets across New Jersey, Long Island and New York markets. Upon completion of the Flushing merger, Flushing Bank will merge into OceanFirst Bank, with OceanFirst Bank emerging as the sole bank. Based on OceanFirst’s closing stock price o…
Top 10 MS news stories of 2025
Throughout 2025, the team at Multiple Sclerosis News Today brought our readers the latest advances and updates in research related to multiple sclerosis (MS). Below are the top 10 most-read news stories we published this year. We look forward to continuing to serve the MS community in 2026 and the years beyond. No. 10 – […] The post Top 10 MS news stories of 2025 appeared first on Multiple Sclerosis News Today.
Coverage Details
Bias Distribution
- 83% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
